Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Ophthalmology. 2017 Oct 27;125(1):139–140. doi: 10.1016/j.ophtha.2017.09.031

Table 1.

Comparison of symptoms severity scores before and after botulinum toxin A injections

Before injections, mean (SD) After injections, mean (SD) Mean Δ (SD) 95% CI p-value
Migraine n=90* 9.34 (0.91) 5.90 (2.48) −3.43 (2.46) [−3.95, −2.92] <0.001
Photophobia n=90* 7.91 (2.05) 5.27 (2.73) −2.64 (2.56) [−3.18, −2.11] <0.001
Dry eye symptoms n=81* 5.40 (3.41) 4.68 (3.34) −0.716 (2.11) [−1.18, −0.249] 0.003
No self-reported or documented diagnosis of dry eye
Migraine n=63 9.17 (0.959) 5.89 (2.65) −3.29 (2.63) [−3.95, −2.62] <0.001
Photophobia n=63 7.68 (1.93) 5.10 (2.60) −2.59 (2.53) [−3.23, −1.95] <0.001
Dry eye n=57 4.40 (3.33) 3.74 (3.20) −0.667 (2.29) [−1.27, −0.060] 0.032
Self-reported or documented diagnosis of dry eye
Migraine n=27 9.70 (0.669) 5.93 (2.07) −3.78 (2.03) [−4.58, −2.98] <0.001
Photophobia n=27 8.44 (2.24) 5.67 (3.03) −2.78 (2.68) [−3.84, −1.72] <0.001
Dry eye symptoms n=24 7.75 (2.29) 6.92 (2.55) −0.833 (1.66) [−1.53, −0.133] 0.022
*

90 individuals responded to the pre/post injection migraine and photophobia severity questions while only 81 individuals responded to the pre/post injection dry eye symptoms severity questions.

SD = standard deviation